Cinacalcet wasprescribed based on the following findings: persistent hyperphosphatemia (15patients); recurrent hypercalcemia (6 patients); and persistent hyperphosphatemia +recurrent hypercalcemia (5 patients) accompanied by PTH levels > 600 pg/mL. Here, PTH is linked to hypercalcemia disease.